T. Khan

Vincristine, cisplatin, teniposide, and cyclophosphamide combination in the treatment of recurrent or metastatic adrenocortical cancer

C. Juhlin, E. Wilander, A. Sundin, 2004, Medical oncology.

177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated with Chemotherapy: Analysis of Outcome, Safety, and Their Determinants

A. Sundin, M. Sandström, Ulrike Garske-Román, 2020, Neuroendocrinology.

Streptozocin and o,p'DDD in the treatment of adrenocortical cancer patients: long-term survival in its adjuvant use.

C. Juhlin, E. Wilander, B. Skogseid, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

11C-metomidate PET imaging of adrenocortical cancer

M. Bergström, B. Långström, C. Juhlin, 2003, European Journal of Nuclear Medicine and Molecular Imaging.

New diagnostic and therapeutic approaches in adrenocortical cancer.

T. Khan, 2004 .

Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity

H. Lundqvist, A. Sundin, M. Sandström, 2018, European Journal of Nuclear Medicine and Molecular Imaging.

Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1346 New Diagnostic and Therapeutic Approaches in Adrenocortical Cancer

T. Khan, 2004 .